Document is current

Any future updates will be listed below

Comparison of the Pathological Response and Adverse Effects of Oxaliplatin and Capecitabine versus Paclitaxel and Carboplatin in the Neoadjuvant Chemoradiotherapy Treatment Approach for Esophageal and Gastroesophageal Junction Cancer: A Randomized Control Trial Study

Crossref DOI link: https://doi.org/10.47176/mjiri.35.140

Published Online: 2021-10-30

Update policy: https://doi.org/10.47176/mjiri/crossmark_policy

About CrossMark